Pharma Industry
Industry: Email Alert RSS FeedPHARMACIA & UPJOHN.(Pharmacia and Upjohn Inc. obtain FDA approval for Camptosar Injection )(Business Brief)(Brief Article)(Product Announcement)
Chemical Market Reporter, November, 1998
PHARMACIA & UPJOHN has reccived full marketing approval from FDA for Camptosar Injection (irinotecan hydrochloride injection) for metastatic colorectal cancer. Camptosar was first approved in 1996 to treat metastic cancer of the colon or rectum with the anticancer agent, fluorouracil. In the first half of 1998, sales of Camptosar were $85 million.
Premium Content Partnership |
HighBeam Research provides an in-depth online archive library of reference works.
Brought to you by CBS MoneyWatch.com
- Best- and Worst-Paid College Degrees
- 6 Things You Should Never Do on Twitter or Facebook
- How Much Sleep Do You Really Need?
- 6 Big Myths about Gas Mileage
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- Design a commission plan that drives sales - Sales Commissions
